• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

AB Science SA

+ Add to Watchlist

A8D:GR

8.914 EUR 0.058 0.65%

As of 02:07:07 ET on 08/29/2014.

Snapshot for AB Science SA (A8D)

Open: 8.916 Day's Range: 8.898 - 8.916 Volume: 0
Previous Close: 8.972 52wk Range: 8.600 - 21.650 1-Yr Rtn: -48.32%

Stock Chart for A8D

No chart data available.
  • A8D:GR 8.916
  • 1D
  • 1M
  • 1Y
8.972
Interactive A8D Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for A8D

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. DAX -
Earnings Per Share (EUR) (ttm) -
Est. EPS (EUR) (12/2014) -0.4800
Est. PEG Ratio -
Market Cap (M EUR) 293.50
Shares Outstanding (M) 32.93
30 Day Average Volume 81
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 04/28/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for A8D

  • Revenue
  • Net Income (M/EUR)
  • Profit Margin (%)

Company Profile & Key Executives for A8D

AB Science SA provides biopharmaceutical services. The Company develops therapies for cancers, inflammatory diseases, and central nervous system diseases in human and veterinary medicine.

Alain MoussyChairman/CEOLaurent GuyChief Financial Officer
Albert AhnPresident:USATom ChapuisDirector:Commercial
More Company Profile & Key Executives for A8D

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil